Versant Capital Management, Inc Regeneron Pharmaceuticals, Inc. Transaction History

Versant Capital Management, Inc

  • $431 Million
  • Q3 2024

A detailed history of Versant Capital Management, Inc transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Versant Capital Management, Inc holds 79 shares of REGN stock, worth $61,818. This represents 0.02% of its overall portfolio holdings.

Number of Shares
79
Previous 68 16.18%
Holding current value
$61,818
Previous $71,000 16.9%
% of portfolio
0.02%
Previous 0.02%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 07, 2024
BUY
$1024.09 - $1201.76 $11,264 - $13,219
11 Added 16.18%
79 $83,000
Q2 2024

Jul 05, 2024
BUY
$883.2 - $1071.19 $32,678 - $39,634
37 Added 119.35%
68 $71,000
Q4 2023

Jan 08, 2024
SELL
$775.18 - $881.7 $1,550 - $1,763
-2 Reduced 6.06%
31 $27,000
Q3 2023

Oct 11, 2023
BUY
$692.45 - $844.37 $692 - $844
1 Added 3.13%
33 $27,000
Q2 2023

Jul 10, 2023
BUY
$700.03 - $830.35 $2,100 - $2,491
3 Added 10.34%
32 $22,000
Q4 2022

Jan 25, 2023
SELL
$705.89 - $766.39 $705 - $766
-1 Reduced 3.33%
29 $0
Q2 2022

Aug 02, 2022
SELL
$548.35 - $738.84 $548 - $738
-1 Reduced 3.23%
30 $18,000
Q2 2021

Jul 22, 2021
BUY
$472.8 - $558.54 $8,037 - $9,495
17 Added 121.43%
31 $17,000
Q1 2021

Apr 27, 2021
BUY
$446.73 - $548.2 $3,127 - $3,837
7 Added 100.0%
14 $7,000
Q1 2020

Apr 17, 2020
SELL
$336.18 - $494.43 $1,008 - $1,483
-3 Reduced 30.0%
7 $3,000
Q4 2019

Jan 28, 2020
SELL
$274.13 - $376.51 $822 - $1,129
-3 Reduced 23.08%
10 $3,000
Q2 2019

Jul 16, 2019
SELL
$299.6 - $414.82 $1,198 - $1,659
-4 Reduced 23.53%
13 $4,000
Q1 2019

Apr 23, 2019
BUY
$372.08 - $439.57 $4,092 - $4,835
11 Added 183.33%
17 $6,000
Q1 2019

Apr 23, 2019
SELL
$372.08 - $439.57 $4,092 - $4,835
-11 Reduced 64.71%
6 $6,000
Q3 2017

Apr 23, 2018
SELL
$431.38 - $504.0 $1,294 - $1,512
-3 Reduced 15.0%
17 $7,000
Q4 2016

Apr 23, 2018
SELL
N/A
-3 Reduced 13.04%
20 $7,000
Q3 2016

Apr 23, 2018
BUY
N/A
2 Added 9.52%
23 $9,000
Q2 2016

Apr 23, 2018
SELL
N/A
-5 Reduced 19.23%
21 $7,000
Q1 2016

Apr 23, 2018
BUY
N/A
2 Added 8.33%
26 $9,000
Q4 2015

Apr 23, 2018
BUY
N/A
24
24 $13,000

Others Institutions Holding REGN

# of Institutions
1,524
Shares Held
84M
Call Options Held
1.14M
Put Options Held
1.48M
View Full List

About REGENERON PHARMACEUTICALS, INC.

REGN Quotes by TradingView
  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $83.9B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Versant Capital Management, Inc Portfolio

Follow Versant Capital Management, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Versant Capital Management, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Versant Capital Management, Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email